INDYLON Hard gelatine capsule Ref.[28122] Active ingredients: Indometacin

Source: Υπουργείο Υγείας (CY)  Revision Year: 2016  Publisher: Medochemie Ltd, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus

4.1. Therapeutic indications

Indomethacin is a non-steroidal anti-inflammatory agent indicated for the active stages of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute musculoskeletal disorders, degenerative joint disease of the hip, low-back pain, and acute gouty arthritis.

Also indicated in inflammation, pain and oedema following orthopaedic procedures; and the treatment of pain and associated symptoms of primary dysmenorrhoea.

4.2. Posology and method of administration

Treatment should begin with the lowest effective dose, which is to be adjusted later according to the response of therapy and the possible undesirable effects. The risk of undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4).

Posology

In chronic conditions, starting therapy with a low dosage, increasing this gradually as necessary, and continuing a trial of therapy for an adequate period (in some cases, up to one month) will give the best results with a minimum of unwanted reactions. The recommended oral dosage range is 50 mg to 200 mg daily in divided doses.

Dosage in dysmenorrhoea: Up to 75 mg a day, starting with onset of cramps or bleeding, and continuing for as long as the symptoms usually last.

Dosage in acute gouty arthritis: 150 mg to 200 mg daily in divided doses until all symptoms and signs subside.

Paediatric population

Paediatric dosage has not been established.

Use in the elderly

Indylon should be used with particular care in older patients who are more prone to adverse reactions.

Method of administration

Indylon capsules are for oral administration. They should be swallowed whole with a glass of water. In order to reduce the possibility of gastro-intestinal disturbances, Indylon should always be taken with food or an antacid.

4.9. Overdose

Toxicity

10 times the therapeutic dose to four premature children lead in one of the cases to transient creatinine elevation. 75-175 mg to toddlers gave mild intoxication. 175-1,500 mg for adults led to mild intoxication, while about 800 mg to 18-year-old gave moderate intoxication.

Symptoms

Nausea, vomiting, diarrhoea, epigastric pain, ulcers, maybe accompanied with bleeding or perforation. Drowsiness, headache, confusion, nervousness, agitation, in severe cases, convulsions and coma. Fluid retention, oedema, hyperkaliemia. Renal effects.

Treatment

If needed gastric lavage and activated charcoal, which maybe repeated. If necessary, antacids. Good urine output should be ensured. The treatment is symptomatic.

6.3. Shelf life

5 years.

6.4. Special precautions for storage

Store below 25°C in the original package, in order to be protected from moisture.

6.5. Nature and contents of container

PVC-Al blisters.

Pack of 30, 50 and hospital packs of 1000 capsules are available.

6.6. Special precautions for disposal and other handling

None.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.